Merck (MRK) Tops Q1 EPS by 14c, Beats on Revenue; Offers FY24 Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/2/2026
- Wall St futures rise ahead of jobs report as bond market steadies, oil slips
- U.S. economy adds 29,000 jobs in September
- Nvidia returns as Morgan Stanley’s Top Pick on attractive valuation
- Citi says rate volatility without Fed repricing is concerning
- BofA's Hartnett sees risk-off mood lasting until dollar peaks
- DataMeds AI's Corexa Pharmacy tops $1M in monthly revenue
- Equities rebound to close higher as surging Treasury yields recede
- onsemi cuts Synaptics deal price to $5.7B after rival bid
- Twilio, Vylor set to join S&P 500 as index reshuffles members
- Amazon and these four U.S. stocks are latest additions to Goldman’s flagship list
Merck (MRK) hikes outlook for 2024 as Q1 print beats analyst estimates
April 25, 2024 6:47 AM EDTMerck (NYSE: MRK) saw its shares climb 1.5% in premarket trading Thursday after the pharma company hiked its outlook for the fiscal year 2024.
For Q1 2024, Merck reported earnings per share (EPS) at $2.07, surpassing analyst expectations of $1.93. The companys revenue for the quarter was $15.8 billion,... More
Merck (MRK) call put ratio 2.6 calls to 1 put into quarter results and outlook
April 24, 2024 10:11 AM EDTMerck (NYSE: MRK) April weekly call option implied volatility is at 49, May is at 21; compared to its 52-week range of 16 to 26 into the expected release of quarter results before the bell on April 25.
... More